BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrade P, Fraga Dias A, Figueiró F, Torres FC, Kawano DF, Oliveira Battastini AM, Carvalho I, Tomich de Paula da Silva CH, Campos JM. 1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line. Future Med Chem 2020;12:689-708. [PMID: 32193951 DOI: 10.4155/fmc-2019-0227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ríos-malváez ZG, Cano-herrera M, Dávila-becerril JC, Mondragón-solórzano G, Ramírez-apan MT, Morales-morales D, Barroso-flores J, Santillán-benítez JG, Unnamatla MB, García-eleno MA, González-rivas N, Cuevas-yañez E. Synthesis, characterization and cytotoxic activity evaluation of 4-(1,2,3-triazol-1-yl) salicylic acid derivatives. Journal of Molecular Structure 2021;1225:129149. [DOI: 10.1016/j.molstruc.2020.129149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Alam MM. 1,2,3-Triazole hybrids as anticancer agents: A review. Arch Pharm (Weinheim) 2022;355:e2100158. [PMID: 34559414 DOI: 10.1002/ardp.202100158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rajasekhar S, Karuppasamy R, Chanda K. Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies. J Comput Chem 2021;42:1736-49. [PMID: 34216033 DOI: 10.1002/jcc.26712] [Reference Citation Analysis]
4 Federico LB, Silva GM, de Fraga Dias A, Figueiró F, Battastini AMO, Dos Santos CBR, Costa LT, Rosa JMC, de Paula da Silva CHT. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening. Int J Biol Macromol 2020;165:3040-50. [PMID: 33736292 DOI: 10.1016/j.ijbiomac.2020.10.136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Dias AF, Scholl JN, Moritz CEJ, Kagami LP, das Neves GM, Eifler-Lima VL, Cruz-López O, Conejo-García A, Sévigny J, Battastini AMO, Campos JM, Figueiró F. New insights into cytotoxic mechanisms of bozepinib against glioblastoma. Eur J Pharm Sci 2021;162:105823. [PMID: 33781855 DOI: 10.1016/j.ejps.2021.105823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gaikwad NB, Bansode S, Biradar S, Ban M, Srinivas N, Godugu C, Yaddanapudi VM. New 3-(1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one-based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis-inducing agents. Arch Pharm (Weinheim) 2021;:e2100074. [PMID: 34346099 DOI: 10.1002/ardp.202100074] [Reference Citation Analysis]
7 Fraga Dias A, Dallemole DR, Bruinsmann FA, Lopes Silva LF, Cruz-López O, Conejo-García A, Oliveira Battastini AM, Campos JM, Guterres SS, Pohlmann AR, Figueiró F. Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma. Nanomedicine (Lond) 2021;16:2095-115. [PMID: 34523353 DOI: 10.2217/nnm-2021-0164] [Reference Citation Analysis]
8 Al Sheikh Ali A, Khan D, Naqvi A, Al-Blewi FF, Rezki N, Aouad MR, Hagar M. Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives. ACS Omega 2021;6:301-16. [PMID: 33458482 DOI: 10.1021/acsomega.0c04595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]